Citation 88000

YASUDA,K: KIZU,H: YAMASHITA,T: KAMEDA,Y: KATO,A: NASH,RJ: FLEET,GWJ: MOLYNEUX,RJ: ASANO,N:. (2002). NEW SUGAR-MIMIC ALKALOIDS FROM THE PODS OF ANGYLOCALYX PYNAERTII.. 65(2)

Citation Details

Title	NEW SUGAR-MIMIC ALKALOIDS FROM THE PODS OF ANGYLOCALYX PYNAERTII.
Authors	YASUDA,K: KIZU,H: YAMASHITA,T: KAMEDA,Y: KATO,A: NASH,RJ: FLEET,GWJ: MOLYNEUX,RJ: ASANO,N:
Year	2002
Volume	65
Issue	2

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Angylocalyx pynaertii (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO:	None
3	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO:	ACTIVE
4	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO:	ACTIVE
5	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO:	ACTIVE
6	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO:	INACTIVE
7	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO:	INACTIVE
8	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO:	INACTIVE
9	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO:	ACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MANNITOL,D: 2-5-IMINO-1-2-5-TRIDEOXY:	None
11	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNITOL,D: 2-5-IMINO-1-2-5-TRIDEOXY:	ACTIVE
12	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNITOL,D: 2-5-IMINO-1-2-5-TRIDEOXY:	INACTIVE
13	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNITOL,D: 2-5-IMINO-1-2-5-TRIDEOXY:	ACTIVE
14	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNITOL,D: 2-5-IMINO-1-2-5-TRIDEOXY:	INACTIVE
15	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNITOL,D: 2-5-IMINO-1-2-5-TRIDEOXY:	ACTIVE
16	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNITOL,D: 2-5-IMINO-1-2-5-TRIDEOXY:	ACTIVE
17	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNITOL,D: 2-5-IMINO-1-2-5-TRIDEOXY:	ACTIVE
18	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MANNOJIRIMYCIN,1-DEOXY:	None
19	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FAGOMINE	None
20	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO: 2-O-BETA-D-GLUCOPYRANOSYL:	None
21	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO: 2-O-BETA-D-GLUCOPYRANOSYL:	INACTIVE
22	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO: 2-O-BETA-D-GLUCOPYRANOSYL:	INACTIVE
23	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO: 2-O-BETA-D-GLUCOPYRANOSYL:	INACTIVE
24	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO: 2-O-BETA-D-GLUCOPYRANOSYL:	INACTIVE
25	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO: 2-O-BETA-D-GLUCOPYRANOSYL:	INACTIVE
26	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO: 2-O-BETA-D-GLUCOPYRANOSYL:	INACTIVE
27	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO: 2-O-BETA-D-GLUCOPYRANOSYL:	INACTIVE
28	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RIBITOL,D: 1-4-DIDEOXY-1-4-IMINO:	None
29	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RIBITOL,D: 1-4-DIDEOXY-1-4-IMINO:	ACTIVE
30	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RIBITOL,D: 1-4-DIDEOXY-1-4-IMINO:	INACTIVE
31	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RIBITOL,D: 1-4-DIDEOXY-1-4-IMINO:	ACTIVE
32	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RIBITOL,D: 1-4-DIDEOXY-1-4-IMINO:	INACTIVE
33	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RIBITOL,D: 1-4-DIDEOXY-1-4-IMINO:	ACTIVE
34	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RIBITOL,D: 1-4-DIDEOXY-1-4-IMINO:	INACTIVE
35	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RIBITOL,D: 1-4-DIDEOXY-1-4-IMINO:	ACTIVE
36	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	GLUCITOL,L: 2-5-IMINO-1-2-5-TRIDEOXY:	None
37	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCITOL,L: 2-5-IMINO-1-2-5-TRIDEOXY:	ACTIVE
38	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCITOL,L: 2-5-IMINO-1-2-5-TRIDEOXY:	INACTIVE
39	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCITOL,L: 2-5-IMINO-1-2-5-TRIDEOXY:	INACTIVE
40	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCITOL,L: 2-5-IMINO-1-2-5-TRIDEOXY:	INACTIVE
41	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCITOL,L: 2-5-IMINO-1-2-5-TRIDEOXY:	ACTIVE
42	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCITOL,L: 2-5-IMINO-1-2-5-TRIDEOXY:	ACTIVE
43	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCITOL,L: 2-5-IMINO-1-2-5-TRIDEOXY:	ACTIVE
44	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FUCITOL,D: 2-5-DIDEOXY-2-5-IMINO:	None
45	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCITOL,D: 2-5-DIDEOXY-2-5-IMINO:	INACTIVE
46	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCITOL,D: 2-5-DIDEOXY-2-5-IMINO:	INACTIVE
47	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCITOL,D: 2-5-DIDEOXY-2-5-IMINO:	INACTIVE
48	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCITOL,D: 2-5-DIDEOXY-2-5-IMINO:	INACTIVE
49	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCITOL,D: 2-5-DIDEOXY-2-5-IMINO:	INACTIVE
50	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCITOL,D: 2-5-DIDEOXY-2-5-IMINO:	ACTIVE
51	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FUCITOL,D: 2-5-DIDEOXY-2-5-IMINO:	INACTIVE
52	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FUCONOJIRIMYCIN,BETA-HOMO:	None
53	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(5-O-BETA-D-GLUCOPYRANOSYL):	None
54	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(5-O-BETA-D-GLUCOPYRANOSYL):	INACTIVE
55	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(5-O-BETA-D-GLUCOPYRANOSYL):	INACTIVE
56	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(5-O-BETA-D-GLUCOPYRANOSYL):	INACTIVE
57	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(5-O-BETA-D-GLUCOPYRANOSYL):	INACTIVE
58	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(5-O-BETA-D-GLUCOPYRANOSYL):	INACTIVE
59	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(5-O-BETA-D-GLUCOPYRANOSYL):	INACTIVE
60	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(5-O-BETA-D-GLUCOPYRANOSYL):	INACTIVE
61	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(HYDROXY-ETHYL-IMINIUMYL):	None
62	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(HYDROXY-ETHYL-IMINIUMYL):	ACTIVE
63	ALPHA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(HYDROXY-ETHYL-IMINIUMYL):	INACTIVE
64	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(HYDROXY-ETHYL-IMINIUMYL):	INACTIVE
65	ALPHA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(HYDROXY-ETHYL-IMINIUMYL):	ACTIVE
66	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(HYDROXY-ETHYL-IMINIUMYL):	INACTIVE
67	ALPHA-L-FUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(HYDROXY-ETHYL-IMINIUMYL):	INACTIVE
68	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO-(HYDROXY-ETHYL-IMINIUMYL):	ACTIVE
69	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	NOJIRIMYCIN,1-6-DIDEOXY:	None
70	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	NOJIRIMYCIN,1-3-4-TRIDEOXY:	None

Citation 88000

Citation Details

Summary

Organisms and Their Experiments (1)

Angylocalyx pynaertii (FABACEAE)

Show SPARQL Queries (1)

Query 1